Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by somweyungguyon Oct 04, 2016 8:36am

138 Views

Post# 25305793

Ronco "theranostic trial for ABDOMINAL SEPSIS"...

Just for fun Spectral...

Tell us about how those with Abdominal Sepsis are doing

After all, endotoxin does reside in the gut....

Rather than giving people a "tummy ache"...

Tell us what you know about Abdominal Sepsis, the last 180 patients and the purpose of the lousy NR yesterday.

Clearly....a man with an advanced degree in business management from Harvard can produce a NR that better explains the current situation.

Thanks in advance,
Sqr

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property